Litcius/Paper detail

Ru(<scp>ii</scp>) and Ir(<scp>iii</scp>) phenanthroline-based photosensitisers bearing<i>o</i>-carborane: PDT agents with boron carriers for potential BNCT

Robert Conway‐Kenny, Albert Ferrer‐Ugalde, Oriol Careta, Xiaoneng Cui, Jianzhang Zhao, Carme Nogués, Rosario Núñez, Justo Cabrera‐González, Sylvia M. Draper

2021Biomaterials Science22 citationsDOI

Abstract

) were obtained for the mono-carborane-phenanthroline complexes (RuCB: 52% and IrCB: 25%). None of the complexes produce dark toxicity in SKBR-3 cells after incubation under photodynamic therapy (PDT) conditions. Remarkably, mono-carboranes RuCB and IrCB were the best internalised by the SKBR-3 cells, demonstrating the first examples of tris-bidentate transition metal-carborane complexes acting as triplet photosensitisers for PDT with a high photoactivity; RuCB or IrCB killed ∼50% of SKBR-3 cells at 10 μM after irradiation. Therefore, the high-boron content and the photoactive properties of these photosensitisers make them potential candidates as dual anti-cancer agents for PDT and Boron Neutron Capture Therapy (BNCT).

Topics & Concepts

CarboraneSonogashira couplingChemistryPhenanthrolineBoronMedicinal chemistryStereochemistryPalladiumInorganic chemistryOrganic chemistryCatalysisBoron Compounds in ChemistryNanoplatforms for cancer theranosticsLuminescence and Fluorescent Materials
Ru(<scp>ii</scp>) and Ir(<scp>iii</scp>) phenanthroline-based photosensitisers bearing<i>o</i>-carborane: PDT agents with boron carriers for potential BNCT | Litcius